The Dialysis and Kidney Transplant Patient

  • Norman B. Levy
  • Adam Mirot

The pertinence of this area can best be understood by noting that in the United States alone there are over 80,000 people who develop renal failure each year, about 325,000 people who are on some form of dialysis, and over 100,000 who have functioning kidney transplants (United States Renal Data System, 2005). Further, more so than many other chronic medical illnesses, this is an area of great need for psychiatric input, both in the evaluation of candidates for treatment as well as of the recipients of transplants (Reichsman and Levy, 1972).


Sexual Dysfunction Dialysis Patient Dialysate Fluid Kidney Transplant Patient United States Renal Data System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abram HS, Moore GL, Westervelt BS Jr. Suicidal behavior in chronic dialysis patients. Am J Psychiatry 1971;127:1199–1204.PubMedGoogle Scholar
  2. Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Olanzapine-pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet 1999;37:177–193.PubMedCrossRefGoogle Scholar
  3. Cohen LM, Germain MJ, Poppel DM. Perspectives on care at the close of life: practical considerations in dialysis withdrawal: “to have that option is a blessing”. JAMA 2003;289:2113–2119.PubMedCrossRefGoogle Scholar
  4. Cohen LM, Germain MJ, Woods AL, Mirot A, Burleson JA. The family perspective of ESRD deaths. Am J Kidney Dis 2005a;45(1):209–212.CrossRefGoogle Scholar
  5. Cohen LM, Levy NB, Tessier E, Germain M. Renal disease. In: Levenson JL, ed. Textbook of Psychosomatic Medicine. Washington, DC: American Psychiatric Publishing, 2005b:483–493.Google Scholar
  6. Cohen LM, McCue J, Germain M, Woods A. Denying the dying: advance directives and dialysis discontinuation. Psychosomatics 1997;38(1):27–34.PubMedGoogle Scholar
  7. Cohen LM, Moss AH, Weisbord SD, Germain MJ. Renal palliative care. J Palliat Med 2006;9(3):975–990.Google Scholar
  8. Cohen LM. Renal Disease. In Rundell JR, Wise, eds. American Psychiatric Press Textbook of Consultation-Liaison Psychiatry. Washington, D.C.: American Psychiatric Press, 1996:573–578.Google Scholar
  9. Curran CF, Blahunka PC, Lawrence I. Acute overdoses of tacrolimus. Transplantation 1996;62(9):1376–1377.PubMedCrossRefGoogle Scholar
  10. DiMartini A, Dew MA, Trzepacz PT. Organ transplantation. In: Levenson J, ed. Textbook of Psychosomatic Medicine. Washington, DC: American Psychiatric Press, 2005:675–699.Google Scholar
  11. DiMartini A, Trzepacz PT, Daviss SR. Prospective study of FK506 side effects: anxiety or akathisia? Biol Psychiatry 1996;40(5):407–411.PubMedCrossRefGoogle Scholar
  12. Fukunishi I, Sugawara Y, Takayama T, Makuuchi M, Kawarasaki H, Surman O. Psychiatric disorders before and after living-related transplantation. Psychosomatics 2001;42:337–343.PubMedCrossRefGoogle Scholar
  13. Inturrissi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002;18(4):S3–S13.CrossRefGoogle Scholar
  14. Iwashige T, Inoue K, Nakajima T. Renal transplantation: psychiatric aspects and interventions. Jpn J Psychiatry Neurol 1990;44(1):7–18.PubMedGoogle Scholar
  15. James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 2004;65(65):752–755.PubMedCrossRefGoogle Scholar
  16. Karlawish J, Quill TE, Meier D, for ACP-ASIM End-of-Life Care Consensus Panel. A consensus-based approach to providing palliative care to patients who lack decision-making capacity. Ann Intern Med 1999;130:835–840.PubMedGoogle Scholar
  17. Kennedy SH, Craven JL, Roin GM. Major depression in renal dialysis patients: an open trial of antidepressant therapy. J Clin Psychiatry 1989;50:60–63.PubMedGoogle Scholar
  18. Kimmel PL. Depression in patients with chronic renal diseases: what we know and what we need to know. J Psychosom Res 2002;53:951–956.PubMedCrossRefGoogle Scholar
  19. Kimmel PL, Gavin C, Miller G, Mendelson WB, Wernli I, Neugarten J. Disordered sleep and noncompliance in a patient with end-stage renal disease. Adv Ren Replace Ther 1997;4(1):55–67.PubMedGoogle Scholar
  20. Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993;3:12–27.Google Scholar
  21. Lam YWF, Banerji S, Hatfield C, Talbert RL. Principles of drug administration in renal insufficiency. Clin Pharmacokinet 1997;32:30–57.PubMedCrossRefGoogle Scholar
  22. Leo RJ, Smith BA, Mori DL. Guidelines for conducting a psychiatric evaluation of the unrelated kidney donor. Psychosomatics 2003;44:452–460.PubMedCrossRefGoogle Scholar
  23. Levenson JL, Glocheski S. Psychological factors affecting end-stage renal disease. Psychosomatics 1991;32:382–389.PubMedGoogle Scholar
  24. Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates: a survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics 1993;34:144–153.Google Scholar
  25. Levy NB, Abram HS, Kemph JP, McKegney FP, Scribner BH. Panel: living or dying: adaptation to hemodialysis. In: Levy NB, ed. Living or Dying: Adaptation to Hemodialysis. Springfield, IL: Charles C. Thomas, 1974:3–29.Google Scholar
  26. Levy NB, Cohen LM, Tessier EG. Renal disease. In: Blumenfield M, Strain T, eds. Psychosomatic medicine. Philadelphia: Williams & Wilkins, 2006:157–175.Google Scholar
  27. Levy NB. Psychiatric considerations in primary medical care of the patient in renal failure. Adv Renal Replacement Ther 2000;7:231–238.CrossRefGoogle Scholar
  28. Levy NB. Psychological aspects of renal transplantation. Psychosomatics 1994;35:427–433.PubMedGoogle Scholar
  29. Levy NB. Psychosomatik und konsutations/liaison-psychiatrie: ein uberblick. Nervenarzt 1989;60:724–731.PubMedGoogle Scholar
  30. Levy NB. Sexual adjustment to maintenance hemodialysis and renal transplantation: national survey by questionnaire: preliminary report. Trans Am Soc Artif Intern Organs 1973;19:323–331.Google Scholar
  31. Levy NB, Wynbrandt GD. The quality of life on maintenance hemodialysis. Lancet 1975;1:1328–1330.PubMedCrossRefGoogle Scholar
  32. Lo B, Quill T, Tulsky J, for the ACP-ASIM End-of-Life Care Consensus Panel. Discussing palliative care with patients. Ann Intern Med 1999;130:744–749.PubMedGoogle Scholar
  33. Lieberman JA, Stroup TS, McEvoy JP, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 22;353(12):1209–1223.CrossRefGoogle Scholar
  34. Lipowski ZJ. Delirium: Acute Brain Failure in Man. Springfield, IL: Charles C. Thomas, 1980.Google Scholar
  35. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little, Brown, 1970.Google Scholar
  36. Mendelson WB, Jain B. An assessment of short-acting hypnotics. Drug Saf 1995;13(4):257–270.PubMedCrossRefGoogle Scholar
  37. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Physical symptoms and quality of life in patients on chronic dialysis: results of the Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant 1999;14:1163–1170.PubMedCrossRefGoogle Scholar
  38. Mori DL, Gallagher P, Milne J. The Structured Interview for Renal Transplantation-SIRT, Psychosomatics 2000;41:393–406.PubMedCrossRefGoogle Scholar
  39. Moss AH. Shared decision-making in dialysis: the new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. Am J Kidney Dis 2001;37(5):1081–1091.PubMedCrossRefGoogle Scholar
  40. Mrvos R, Hodgman M, Krenzelok EP. Tacrolimus (FK 506) overdose: a report of five cases. J Toxicol Clin Toxicol 1997;35(4):395–399.PubMedCrossRefGoogle Scholar
  41. Muslin HL. On acquiring a kidney. Am J Psychiatry 1971;127:1185–1188.PubMedGoogle Scholar
  42. Neely KJ, Roxe DM. Palliative care/hospice and the withdrawal of dialysis. J Palliat Med 2000;3(1):57–67.PubMedCrossRefGoogle Scholar
  43. Nghiem DD. Role of pharmacologic enhancement of p450 in cyclosporine overdose. Transplantation 2002;74(9):1355–1356.PubMedCrossRefGoogle Scholar
  44. Olbrisch ME, Levenson JL, Hamer R. The PACT: a rating scale for the study of clinical decision making in psychosocial screening of organ transplant candidates. Clin Transplant 1989;3:166–169.Google Scholar
  45. Parker TF. Trends and concepts in the prescription and delivery of dialysis in the United States. Semin Nephrol 1992;12:267–275.PubMedGoogle Scholar
  46. Pieta J, Millar T, Zacharias J, Fine A, Kryger M. Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep 1998;21(6):617–622.PubMedGoogle Scholar
  47. Reichsman F, Levy NB. Adaptation to hemodialysis: a four-year study of 25 patients. Arch Intern Med 1972;138:859–865.CrossRefGoogle Scholar
  48. Renal Physicians Association (RPA), and American Society of Nephrology. Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis. Washington, DC: RPA, 2000.Google Scholar
  49. Rothschild AJ. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry 1992;53(suppl):69–79.PubMedGoogle Scholar
  50. Rundell JR, Hall RCW. Psychiatric characteristics of consecutively evaluated outpatient renal transplant candidates and comparisons with consultation-liaison inpatients. Psychosomatics 1997;38:269–276.PubMedGoogle Scholar
  51. Sein AJ, Chodorowski Z, Kujawska H. Acute suicidal intoxication with tacrolimus in a kidney transplant patient. Przegl Lek 2005;62(6):517–518.Google Scholar
  52. Sketris IS, Onorato L, Yatscoff RW, Givner M, Nicol D, Abraham I. Eight days of cyclosporine overdose: a case report. Pharmacotherapy 1993;13(6):658–660.PubMedGoogle Scholar
  53. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004;43(4):663–670.PubMedCrossRefGoogle Scholar
  54. Surman OS. Psychiatric aspects of organ transplantation. Am J Psychiatry 1989;146:872–882.Google Scholar
  55. Twillman RK, Manetto C, Wellisch DK, Wolcott DL. The Transplant Evaluation Rating Scale: a revision of the psychosocial levels system for evaluating organ transplant candidates. Psychosomatics 1993;34:144–153.PubMedGoogle Scholar
  56. United States Renal Data System. USRDS 2002 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases, 2002.Google Scholar
  57. United States Renal Data System. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases, 2005:5–8.Google Scholar
  58. Valderrqabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis 2001;38:443–464.CrossRefGoogle Scholar
  59. Walker S, Fine A, Kryger MH. Sleep complaints are common in dialysis unit. Am J Kidney Dis 1995;28:372.Google Scholar
  60. Weisbord SD, Carmody SS, Bruns FJ, et al. Symptom burden, quality-of-life advance care planning, and the potential value of palliative care in severely ill hemodialysis patients. Nephrol Dialysis Transplant 2003;18:1345–1352.CrossRefGoogle Scholar
  61. Wong EH, Chan NN, Sze KH. Serotonin syndrome in a renal transplant patient. J R Soc Med 2002;95(6):304–305.PubMedCrossRefGoogle Scholar
  62. Zylber-Katz E, Putterman C, Caraco Y. Multiple drug overdose in a kidney transplant patient. Ther Drug Monit 1994;16(3):327–331.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Norman B. Levy
    • 1
  • Adam Mirot
    • 2
  1. 1.University of Southern CaliforniaLos AngelesUSA
  2. 2.Tufts University School of MedicineSpringfieldUSA

Personalised recommendations